
JCI - About the Journal of Clinical Investigation
Email staff@the-jci.org or call 734-222-6050. To avoid confusion regarding correspondence, inquiries, and decisions, the JCI will typically communicate only with the responsible party/corresponding …
JCI - Welcome
Mar 16, 2026 · In this issue of the JCI, Köcher et al. have demonstrated that ERG overexpression in human prostate cancer cells rewired DNA double-strand break repair toward a poly (ADP-ribose) …
JCI - Welcome
Copyright © 2026 American Society for Clinical Investigation ISSN: 0021-9738 (print), 1558-8238 (online)
JCI - Author Information Center
The JCI considers research submissions in the following categories [Top of page] Click the category name for formatting instructions; or go to How to submit your manuscript for the first time (new …
JCI - Submission instructions - first
Submit a manuscript directly to the JCI through your account on the JCI’s submission website. Follow the instructions to either register for an account or access your existing account. Click the button …
JCI - The promise of GLP-1 receptor agonists for neurodegenerative …
Feb 16, 2026 · Glucagon-like peptide-1 receptor agonists (GLP-1RAs), established therapies for type 2 diabetes and obesity, are increasingly recognized for their potential in neurodegenerative diseases. …
JCI - The gut microbiome and cancer response to immune checkpoint ...
Feb 3, 2025 · The field of the microbiome and immunotherapy has skyrocketed since 2015 when two studies demonstrated a fascinating phenomenon in mice: certain gut bacteria could enhance the …
JCI Insight - An insider’s guide to understanding and obtaining an NIH ...
Jun 23, 2025 · JCI Insight. 2024;9 (5):e179940. View this article via: JCI Insight PubMed Google Scholar Chasan-Taber L. Writing Dissertation and Grant Proposals. Chapman and Hall/CRC Press; 2014. …
JCI - Volume 136, Issue 7
Apr 1, 2026 · Konishi et al. report a unique thick microtubule bundle organization that is required to generate expansive and thin cell morphology during alveolar type 2 cell differentiation into alveolar …
JCI - The science of safety: adverse effects of GLP-1 receptor agonists ...
Feb 16, 2026 · The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications